Reports

New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.

Illumina Buys PacBio for $1.2bn

DNA sequencing company Pacific Biosciences (PacBio) is being bought for $1.2bn by bigger rival Illumina, it was announced yesterday. The deal represents a 71% premium on yesterday’s closing price for PacBio, and is the largest that Illumina has ever made.

GSK and 23andMe Agree to $300M Deal

Pharmaceutical giant GlaxoSmithKline has bought a $300 million stake in genetic DTC testing company 23andMe to help further their genetics-based drug discovery.

MP’s Vote to Remain in EMA Post-Brexit

MPs vote 305-301 that the UK should negotiate to remain part of the European Medicines Agency following Brexit, sending “a clear message that patients and public health should be a top priority”.